Sourcing high-purity short peptides for epigenetic and neurobiological assays requires rigorous analytical validation and consistent lot-to-lot reliability. PX1 Research serves as a trusted primary vendor for laboratory-grade bioregulators, providing high-purity compounds backed by independent third-party verification.
Sourcing high-purity short peptides for epigenetic and neurobiological assays requires rigorous analytical validation and consistent lot-to-lot reliability. PX1 Research serves as a trusted primary vendor for laboratory-grade bioregulators, providing high-purity compounds backed by independent third-party verification.
Finding a qualified gene activation peptide Cortagen supplier requires selecting a vendor that delivers USA-manufactured, highly purified Ala-Glu-Asp-Pro tetrapeptide exclusively intended for *in vitro* and preclinical laboratory applications. Reliable suppliers provide lot-specific third-party Certificates of Analysis (COA) confirming greater than 98% purity via reverse-phase high-performance liquid chromatography (RP-HPLC), sequence confirmation through electrospray ionization mass spectrometry (ESI-MS), and sub-threshold endotoxin levels.
PX1 Research fulfills these requirements for academic institutions, biotechnology enterprises, and clinical research facilities. All compounds distributed through our platform are manufactured under strict Good Manufacturing Practice (GMP) guidelines in state-of-the-art domestic facilities and analyzed in ISO 17025 accredited testing laboratories to ensure absolute experimental reproducibility.
Cortagen is a synthetic short-chain peptide bioregulator comprising four amino acids: L-alanyl-L-glutamyl-L-aspartyl-L-proline (sequence: AEDP or H-Ala-Glu-Asp-Pro-OH). It belongs to the Khavinson peptide class, which was originally developed to investigate site-specific gene expression and chromatin remodeling in eukaryotic cellular systems. With a molecular weight of approximately 444.4 g/mol, its small steric footprint allows high diffusibility across cellular membranes and nuclear pores during *in vitro* assays.
Solid-phase peptide synthesis (SPPS) is the standard method for producing high-purity Cortagen. By systematically coupling protected amino acid residues onto an insoluble polymeric resin matrix, chemists achieve precise sequence integrity. Chemical synthesis ensures the elimination of biological contaminants such as viruses, prions, or non-target proteins commonly associated with tissue-derived extracts.
When evaluating a gene activation peptide Cortagen supplier, researchers must ensure that chemical synthesis procedures incorporate stringent washing and cleavage cycles. Residual trifluoroacetic acid (TFA) salts and truncated peptide fragments must be systematically purged using preparative RP-HPLC to yield a refined lyophilized powder suitable for biochemical assays across diverse cell lines.
Preclinical investigations demonstrate that short peptides like Cortagen interact directly with double-stranded DNA and histones within the cell nucleus. Evidence suggests that short amino acid sequences fit into the major and minor grooves of DNA in a sequence-specific manner. This physical association is hypothesized to induce localized chromatin unwinding, shifting dense heterochromatin into transcriptionally active euchromatin.
In vitro data indicate that Cortagen promotes targeted histone acetylation and DNA demethylation in specific promoter regions. By altering local electrostatic charges between positively charged histone tails and negatively charged DNA phosphate backbones, Cortagen exposes promoter regions to RNA polymerase II complexes and transcription factors. This mechanism provides a model for studying selective gene activation without altering the underlying genomic sequence.
Furthermore, rodent models demonstrate that Cortagen exerts tissue-specific activity, particularly within central nervous system tissues. Preclinical literature links AEDP exposure to increased transcript levels of neurotrophic factors, antioxidant enzymes, and structural neural proteins. Researchers utilizing PX1 Research catalog items leverage these mechanisms to study cellular longevity, neuronal differentiation, and stress-response pathways.
Preclinical research examining Cortagen primarily focuses on neuroregeneration, ischemic brain injury recovery, and age-related neurodegeneration models. In murine models of peripheral nerve injury and cerebral ischemia, administration of research-grade Cortagen demonstrated accelerated functional recovery and diminished lesion volumes compared to control cohorts.
Biochemical analyses of brain tissue homogenates in these rodent models revealed significant down-regulation of pro-inflammatory cytokines, including TNF-alpha, IL-1beta, and IL-6. Concurrently, upregulated expression of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) was observed. These findings suggest that Cortagen may serve as a powerful probe for investigating endogenous neuroprotective cascades and microglial polarization dynamics.
Additional research studies highlight the capacity of Cortagen to mitigate oxidative stress in cultured primary cortical neurons. By boosting superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzymatic activities, the peptide protects mitochondrial membrane potential during induced oxygen-glucose deprivation (OGD) experiments. Researchers can review detailed mechanistic literature through our peptide research hub.
To contextualize Cortagen within the broader field of peptide bioregulators, investigators frequently run comparative assays alongside structural or functional analogs. Key compounds in this class include Epitalon, Pinealon, and Vilon. While all four compounds modulate gene expression via chromatin interaction, their primary target tissues and functional outcomes exhibit clear divergence in experimental models.
Cortagen (Ala-Glu-Asp-Pro) specifically target CNS pathways, exhibiting marked tropism for cortical and peripheral neuronal structures. In contrast, Epitalon (Ala-Glu-Asp-Gly) is predominantly investigated for its capacity to upregulate telomerase activity and regulate pineal gland melatonin synthesis. Meanwhile, Pinealon (Glu-Asp-Arg) targets cellular protection against reactive oxygen species in cerebrovascular models, and Vilon (Lys-Glu) is utilized primarily in immunomodulatory and connective tissue synthesis studies.
Selecting the appropriate compound depends on the target signaling pathway under investigation. The table below highlights key parameter differences across these synthetic bioregulator peptides:
Procuring research compounds from a qualified supplier requires verifying strict quality benchmarks before initiating laboratory assays. Inferior peptide preparations containing synthesis byproducts, residual solvents, or heavy metals introduce confounding variables that compromise data integrity and ruin long-term cell cultures.
A premier gene activation peptide Cortagen supplier must provide clear analytical verification for every manufacturing batch. PX1 Research adheres to a comprehensive quality control protocol involving independent analytical testing:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity. PX1 Research guarantees a minimum purity threshold of >98%, ensuring that optical density readings represent the target tetrapeptide rather than truncated deletion sequences. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular weight and structural identity, matching the theoretical mass of 444.4 g/mol. 3. Endotoxin Testing (LAL Assay): Quantifies lipopolysaccharide (LPS) contamination. Our strict standards mandate endotoxin levels below 0.01 EU/mg, making the material safe for sensitive *in vitro* cellular assays and *in vivo* animal protocols. 4. Nuclear Magnetic Resonance (NMR) Spectroscopy: Validates correct amino acid side-chain connectivity and structural conformation.
Detailed explanations of these analytical procedures are available in our guide on peptide purity testing standards.
Maintaining structural integrity during storage and preparation is critical for reproducible experimental outcomes. Cortagen is supplied by PX1 Research as a sterile, lyophilized (freeze-dried) white powder packaged under an inert argon atmosphere to prevent oxidation and hydrolytic degradation.
Upon receipt, un-reconstituted lyophilized Cortagen should be stored in a freezer at -20°C or -80°C for long-term stability (up to 24 months). Exposure to room temperature during transit for short durations does not compromise peptide stability, but immediate cold storage upon arrival is recommended.
For reconstitution, researchers should use sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile Normal Saline (0.9% NaCl), depending on downstream assay compatibility. The lyophilized cake should be dissolved by gently swirling the vial rather than vigorous vortexing, which can introduce mechanical shear stress. Reconstituted solution aliquots should be stored at 2°C to 8°C for up to 30 days, or frozen in single-use aliquots at -20°C to eliminate repeated freeze-thaw cycles. Institutional buyers seeking bulk supply for large-scale projects can apply through our wholesale laboratory portal.
PX1 Research has established itself as a premier domestic supplier of research-grade peptides by maintaining uncompromising standards of transparency, speed, and quality control. We recognize that academic and industrial research projects operate on strict timelines and demand verifiable reproducibility.
All PX1 Research products are manufactured in domestic, GMP-compliant facilities located in the United States. Orders ship directly from our fulfillment centers in California and Arizona, ensuring rapid, reliable delivery without the customs delays or temperature excursions common with overseas vendors. Orders placed Monday through Friday ship same-day.
Every batch of Cortagen is accompanied by a publicly accessible, lot-traceable COA performed by an accredited ISO 17025 third-party laboratory. By eliminating intermediary resellers and maintaining full control over our supply chain, PX1 Research provides researchers with high-grade reagents designed to deliver consistent, publishable results.
What is Cortagen and how is it defined in research settings?
Cortagen is a synthetic short-chain tetrapeptide with the amino acid sequence L-alanyl-L-glutamyl-L-aspartyl-L-proline (Ala-Glu-Asp-Pro). It is classified as a bioregulating peptide studied in cell biology and neurobiology for its interaction with DNA and chromatin structures.
What preclinical models utilize Cortagen?
Cortagen is primarily investigated in rodent models of ischemic brain injury, peripheral nerve trauma, age-related neurodegeneration, and in vitro primary neuronal cell culture models examining gene expression and oxidative stress.
How does PX1 Research verify the purity of its Cortagen?
PX1 Research verifies every lot using independent third-party laboratories. Quality testing includes RP-HPLC for purity (>98%), ESI-MS for molecular identity, and LAL assays to ensure endotoxin levels remain under 0.01 EU/mg.
Is Cortagen approved for human use or medical therapy?
No. Cortagen is strictly a research chemical designated for laboratory, in vitro, and preclinical animal investigation. It is not approved by the FDA for human consumption, diagnosis, prevention, or medical treatment.
What solvent is recommended for reconstituting Cortagen in the laboratory?
Reconstitution is typically performed using sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS), depending on the requirements of the specific cell culture or animal model assay.
How should lyophilized and reconstituted Cortagen be stored?
Lyophilized Cortagen powder should be stored at -20°C or -80°C for long-term stability. Once reconstituted into liquid solution, aliquots should be kept at 2°C to 8°C for short-term use (up to 30 days) or freeze-thawed once in single-use aliquots at -20°C.
How does Cortagen compare structurally to Epitalon?
Cortagen (Ala-Glu-Asp-Pro) and Epitalon (Ala-Glu-Asp-Gly) share three N-terminal amino acids but differ in their C-terminal residue (Proline versus Glycine), resulting in distinct tissue tropism and downstream cellular targets.
Where are PX1 Research products manufactured and shipped from?
All PX1 Research compounds are manufactured in domestic, GMP-compliant facilities in the United States and shipped directly from fulfillment centers in California and Arizona with same-day shipping on weekday orders.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.